Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roflumilast Cream in Mild Atopic Dermatitis
NCT00746382Phase 2Withdrawn
- Sponsor
- AstraZeneca
- Start
- Nov 2008
- Primary completion
- Jun 2009
01
Overview
A Phase 2 trial of roflumilast vehicle cream in atopic dermatitis (AD), sponsored by AstraZeneca. Planned start Nov 2008; status: withdrawn.
02
Drugs
roflumilast vehicle cream
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT00746382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00746382.